<?xml version="1.0" encoding="UTF-8"?>
<p>Changes in antiviral guidance and multiple sources of information about antivirals presented a serious challenge to LHDs. This was the most widely cited issue both early and late in the pandemic, and was described as 'very challenging' by more than a third of health departments. One LHD noted, 
 <italic>"Changing guidance made it difficult to determine appropriate recipients." </italic>Other participants indicated that state and federal antiviral guidance during H1N1 differed from what they had anticipated, particularly with respect to the target population for stockpiled antivirals. This discrepancy required their health departments to revise their planned activities to support this strategy. As several respondents indicated,
</p>
